Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.33 Analyst target: $6.00 Upside: 351.13%
NanoViricides, Inc., a nanobiopharmaceutical company, discovers, develops and markets drugs for the treatment of viral infections. The company is headquartered in Shelton, Connecticut.
See the full interactive analysis & chart →Informational only — not investment advice.